Document and Entity Information
Document and Entity Information | Dec. 11, 2023 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | false |
Document Period End Date | Dec. 11, 2023 |
Entity File Number | 000-51173 |
Entity Registrant Name | Gyre Therapeutics, Inc. |
Entity Central Index Key | 0001124105 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 56-2020050 |
Entity Address, Address Line One | 12770 High Bluff Drive |
Entity Address, Address Line Two | Suite 150 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92130 |
City Area Code | 619 |
Local Phone Number | 949-3681 |
Title of 12(b) Security | Common Stock |
Trading Symbol | GYRE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |